Compare CMMB & TGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMMB | TGHL |
|---|---|---|
| Founded | 2004 | 2020 |
| Country | Israel | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9M | 11.9M |
| IPO Year | 2023 | 2024 |
| Metric | CMMB | TGHL |
|---|---|---|
| Price | $1.56 | $0.71 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | 44.2K | ★ 177.3K |
| Earning Date | 11-27-2026 | 12-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.67 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $35.38 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.92 | $0.27 |
| 52 Week High | $2.99 | $2.48 |
| Indicator | CMMB | TGHL |
|---|---|---|
| Relative Strength Index (RSI) | 63.04 | 55.99 |
| Support Level | $1.44 | $0.33 |
| Resistance Level | $1.64 | $0.88 |
| Average True Range (ATR) | 0.13 | 0.06 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 94.92 | 92.16 |
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
The Growhub Ltd operates as the intersection of technology and supply chain management in the food industry, focusing on enhancing product traceability and authenticity. With a commitment to innovation and sustainability, the company has developed a multi-faceted approach to address industry challenges. Its business currently comprises two main divisions, which are the Traceability and Authenticity Solutions and Carbon Project Development.